Glutathione-Responsive Nano-Prodrug Mediates Synergistic Photothermal Chemotherapy for Tumor Inhibition
Molecular Pharmaceutics · 02.11.2026 · 23 (11) · 5691-5703
DOI: 10.1021/acs.molpharmaceut.6c00801 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Pharmaceutics, online erschienen am 28.09.2026. Verfasst von Yu Jiang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Fujian Provincial Key Laboratory of Tumor Biotherapy Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou350014, Chi…. Hauptthemen laut MEDLINE: Prodrugs, Glutathione, Photothermal Therapy, Nanoparticles. Die Arbeit nennt 43 Literaturangaben. Gefördert von: National Natural Science Foundation of China (NSFC), Natural Science Foundation of Fujian Province, High-Level Talent Program of Fujian Provincial Cancer Hospital.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Photothermal therapy (PTT) offers the advantages of noninvasiveness and high selectivity, while chemotherapy shows potent antitumor activity. However, their standalone applications are limited by insufficient photothermal ablation efficacy and chemotherapeutic resistance, respectively. To address these challenges, we developed a novel boron dipyrromethene (BODIPY)-based scaffold featuring “barrier-free” rotators and an intramolecular charge-transfer (ICT) effect to enhance photothermal performance. Two chlorambucil (CLB) molecules were conjugated to the scaffold via a glutathione (GSH)-sensitive disulfide linker. The resulting prodrug was further encapsulated by an amphiphilic mPEG-b-PCL copolymer to construct a nanoplatform that integrates efficient photothermal therapy with tumor microenvironment-responsive drug release. Both in vitro and in vivo studies confirmed selective tumor accumulation through the enhanced permeability and retention (EPR) effect, significant tumor growth inhibition upon laser irradiation, and low systemic toxicity. This work provides a promising strategy for effective and safe combination photothermal chemotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Fujian Provincial Key Laboratory of Tumor Biotherapy Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou350014, China.
- Institute of Medical-Engineering Interdisciplinary Research, Fuzhou University, Fuzhou350108, China.
- Key Laboratory of Molecule Synthesis and Function Discovery Fujian Province University College of Chemistry, Fuzhou University, Fuzhou350108, China.
- College of Biological Science and Engineering, Fuzhou University, Fuzhou350116, China.
- National & Local Joint Biomedical Engineering Research Center on Photodynamic Technologies College of Chemistry, Fuzhou University, Fuzhou350108, China.
- Department of Gynecology Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, Fujian350014, PR China.
ORCID-Profile: Jianyong Liu, Qinying Liu
Förderung
- National Natural Science Foundation of China (NSFC)
- Natural Science Foundation of Fujian Province
- High-Level Talent Program of Fujian Provincial Cancer Hospital
- Fujian Provincial Science and Technology Innovation Joint Funding Project
Zitieren
APA
Jiang, Y., Guo, C., Sun, Z., Du, K., Liang, Y., Zhuang, J., Sarfraz, A., Sun, Y., Liu, J., & Liu, Q. (2026). Glutathione-Responsive Nano-Prodrug Mediates Synergistic Photothermal Chemotherapy for Tumor Inhibition. Molecular Pharmaceutics, 23(11), 5691-5703. https://doi.org/10.1021/acs.molpharmaceut.6c00801
Vancouver
Jiang Y, Guo C, Sun Z, Du K, Liang Y, Zhuang J, et al. Glutathione-Responsive Nano-Prodrug Mediates Synergistic Photothermal Chemotherapy for Tumor Inhibition. Molecular Pharmaceutics. 2026;23(11):5691-5703. doi:10.1021/acs.molpharmaceut.6c00801
BibTeX
@article{Jiang2026,
author = {Jiang, Yu and Guo, Chen and Sun, Zhenkun and Du, Kaixin and Liang, Yinbin and Zhuang, Junwei and Sarfraz, Aqsa and Sun, Yang and Liu, Jianyong and Liu, Qinying},
title = {Glutathione-Responsive Nano-Prodrug Mediates Synergistic Photothermal Chemotherapy for Tumor Inhibition},
journal = {Molecular Pharmaceutics},
year = {2026},
volume = {23},
number = {11},
pages = {5691--5703},
doi = {10.1021/acs.molpharmaceut.6c00801}
}
EUVIMED